首页> 外文会议>American Peptide Symposium >Structure-Antibacterial Activity Relationship of Cyclic Lipodepsipeptide Antibiotic Fusaricidin A
【24h】

Structure-Antibacterial Activity Relationship of Cyclic Lipodepsipeptide Antibiotic Fusaricidin A

机译:循环脂质肽抗生素Fusaricidin A的结构 - 抗菌活性关系

获取原文

摘要

Fusaricidin A is a cyclic lipodepsipeptide originally isolated from Bacillus polymyxa KT-8 strain, and exhibits promising activity against various kinds of fungi and Gram-positive bacteria, including methicillin-resistant S. aureus [1]. Fusaricidin's relatively simple structure and potent antimicrobial activity make this natural product particularly interesting lead structure for the development of new and more potent antibiotics. In order to investigate structural basis for fusaricidin's antimicrobial activity, and to define its minimal bioactive pharmacophore, we have synthesized fusaricidin A's analogs that differ in the lipid tail part and alanine-scanning analogs. Defining the minimal structural requirements responsible for fusaricidin's antibiotic activity may facilitate chemical synthesis of the antibiotic by reducing structural complexity and promote judicious chemical modifications for modulation of its pharmacological or physiochemical properties.
机译:Fusaricidin A是最初从芽孢杆菌Pyperyyxa Kt-8菌株分离的循环脂质肽肽,并且对各种真菌和革兰氏阳性细菌具有有前途的活性,包括耐甲氧西林的金黄色葡萄球菌[1]。 Fusaricidin的结构相对简单,有效的抗菌活性使得这种天然产品具有特别有趣的铅结构,用于开发新的和更有效的抗生素。为了调查Fusaricidin抗微生物活性的结构基础,并确定其最小的生物活性药物体,我们已经合成了脂质尾部和丙氨酸扫描类似物不同的类似物。定义负责Fusaricidin抗生素活性的最小结构要求可以通过降低结构复杂性并促进调节其药理学或生理化学性质的明智化学改性来促进抗生素的化学合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号